Ancora Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.2M | Buy |
130,537
+126,263
| +2,954% | +$17.7M | 0.39% | 53 |
|
|
2025
Q4 | $525K | Buy |
4,274
+1,418
| +50% | +$172K | 0.01% | 532 |
|
|
2025
Q3 | $317K | Sell |
2,856
-193
| -6% | -$21.9K | 0.01% | 631 |
|
|
2025
Q2 | $338K | Buy |
3,049
+3
| +0.1% | +$319 | 0.01% | 614 |
|
|
2025
Q1 | $341K | Buy |
3,046
+3
| +0.1% | +$310 | 0.01% | 601 |
|
|
2024
Q4 | $281K | Sell |
3,043
-296
| -9% | -$26.7K | 0.01% | 638 |
|
|
2024
Q3 | $280K | Sell |
3,339
-331
| -9% | -$25.3K | 0.01% | 623 |
|
|
2024
Q2 | $252K | Sell |
3,670
-97
| -3% | -$6.47K | 0.01% | 614 |
|
|
2024
Q1 | $276K | Sell |
3,767
-216
| -5% | -$16.6K | 0.01% | 606 |
|
|
2023
Q4 | $323K | Sell |
3,983
-315
| -7% | -$24.5K | 0.01% | 578 |
|
|
2023
Q3 | $322K | Buy |
4,298
+64
| +2% | +$4.92K | 0.01% | 562 |
|
|
2023
Q2 | $326K | Buy |
4,234
+15
| +0.4% | +$1.2K | 0.01% | 546 |
|
|
2023
Q1 | $350K | Buy |
4,219
+13
| +0.3% | +$1.08K | 0.01% | 533 |
|
|
2022
Q4 | $361K | Sell |
4,206
-68
| -2% | -$5.38K | 0.01% | 544 |
|
|
2022
Q3 | $264K | Sell |
4,274
-783
| -15% | -$49.4K | 0.01% | 661 |
|
|
2022
Q2 | $313K | Buy |
5,057
+16
| +0.3% | +$991 | 0.01% | 633 |
|
|
2022
Q1 | $300K | Buy |
5,041
+217
| +4% | +$13.9K | 0.01% | 688 |
|
|
2021
Q4 | $350K | Buy |
4,824
+815
| +20% | +$56.1K | 0.01% | 639 |
|
|
2021
Q3 | $280K | Sell |
4,009
-753
| -16% | -$52.9K | 0.01% | 693 |
|
|
2021
Q2 | $328K | Sell |
4,762
-461
| -9% | -$30.8K | 0.01% | 650 |
|
|
2021
Q1 | $338K | Buy |
5,223
+40
| +0.8% | +$2.58K | 0.01% | 611 |
|
|
2020
Q4 | $302K | Sell |
5,183
-410
| -7% | -$24.7K | 0.01% | 558 |
|
|
2020
Q3 | $353K | Sell |
5,593
-962
| -15% | -$66.7K | 0.01% | 500 |
|
|
2020
Q2 | $504K | Buy |
6,555
+514
| +9% | +$39.4K | 0.02% | 422 |
|
|
2020
Q1 | $452K | Sell |
6,041
-351
| -5% | -$24.3K | 0.02% | 485 |
|
|
2019
Q4 | $415K | Sell |
6,392
-6,287
| -50% | -$409K | 0.02% | 528 |
|
|
2019
Q3 | $804K | Buy |
12,679
+48
| +0.4% | +$3.14K | 0.04% | 363 |
|
|
2019
Q2 | $854K | Buy |
12,631
+260
| +2% | +$17.1K | 0.04% | 318 |
|
|
2019
Q1 | $805K | Sell |
12,371
-2,301
| -16% | -$153K | 0.04% | 332 |
|
|
2018
Q4 | $918K | Sell |
14,672
-180
| -1% | -$12.6K | 0.04% | 299 |
|
|
2018
Q3 | $1.15M | Sell |
14,852
-1,075
| -7% | -$81.2K | 0.04% | 329 |
|
|
2018
Q2 | $1.13M | Sell |
15,927
-1,968
| -11% | -$139K | 0.05% | 317 |
|
|
2018
Q1 | $1.35M | Sell |
17,895
-1,702
| -9% | -$135K | 0.06% | 281 |
|
|
2017
Q4 | $1.4M | Sell |
19,597
-11,127
| -36% | -$845K | 0.07% | 247 |
|
|
2017
Q3 | $2.49M | Sell |
30,724
-191
| -0.6% | -$14.6K | 0.14% | 188 |
|
|
2017
Q2 | $2.19M | Sell |
30,915
-2,462
| -7% | -$164K | 0.14% | 185 |
|
|
2017
Q1 | $2.27M | Buy |
33,377
+1,050
| +3% | +$73.8K | 0.15% | 184 |
|
|
2016
Q4 | $2.31M | Buy |
32,327
+27,438
| +561% | +$2.04M | 0.17% | 170 |
|
|
2016
Q3 | $387K | Buy |
4,889
+157
| +3% | +$12.8K | 0.04% | 374 |
|
|
2016
Q2 | $395K | Buy |
4,732
+560
| +13% | +$49.7K | 0.05% | 351 |
|
|
2016
Q1 | $383K | Buy |
4,172
+810
| +24% | +$73K | 0.05% | 348 |
|
|
2015
Q4 | $340K | Hold |
3,362
| – | – | 0.04% | 368 |
|
|
2015
Q3 | $330K | Hold |
3,362
| – | – | 0.04% | 368 |
|
|
2015
Q2 | $394K | Buy |
+3,362
| New | +$367K | 0.05% | 358 |
|
|
2015
Q1 | – | Sell |
-3,562
| Closed | -$362K | – | 380 |
|
|
2014
Q4 | $336K | Buy |
+3,562
| New | +$368K | 0.04% | 373 |
|
Other funds holding GILD
VCM
VPM
Ancora Advisors's GILD Position: Q1 2026 in Review
Ancora Advisors increased its Gilead Sciences (GILD) stake by 2,954% in Q1 2026, buying an estimated $17.7M and bringing the position to 130,537 shares worth $18.2M. The position accounts for 0.39% of the portfolio, ranked #53.
Ancora Advisors first reported a position in GILD in Q4 2014 and has held it in 45 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Ancora Advisors held 130,537 shares of Gilead Sciences worth $18.2M as of Q1 2026.
- Ancora Advisors bought 126,263 Gilead Sciences shares in Q1 2026, an estimated $17.7M.
- Gilead Sciences made up 0.39% of Ancora Advisors's portfolio in Q1 2026, its #53 holding.
- Ancora Advisors first reported a position in Gilead Sciences in Q4 2014 and has held it in 45 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.